WO2019135420A1 - Composite using porous material and polymer, and use thereof - Google Patents

Composite using porous material and polymer, and use thereof Download PDF

Info

Publication number
WO2019135420A1
WO2019135420A1 PCT/KR2018/000113 KR2018000113W WO2019135420A1 WO 2019135420 A1 WO2019135420 A1 WO 2019135420A1 KR 2018000113 W KR2018000113 W KR 2018000113W WO 2019135420 A1 WO2019135420 A1 WO 2019135420A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
physiologically active
acid
active substance
weight
Prior art date
Application number
PCT/KR2018/000113
Other languages
French (fr)
Korean (ko)
Inventor
김배용
이병일
Original Assignee
김배용
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김배용 filed Critical 김배용
Priority to PCT/KR2018/000113 priority Critical patent/WO2019135420A1/en
Publication of WO2019135420A1 publication Critical patent/WO2019135420A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a composite using a porous material and a polymer and a use thereof. More particularly, the present invention relates to a composite material comprising a porous material, a physiologically active substance supported on the micropores of a volcanic soil and an ionic polymer The present invention relates to a method for protecting a biologically active material from external environment by capping and preventing self aggregation by forming a network due to Van der Waals bonding between an ionic polymer residue exposed on a surface and a nonionic polymer after sealing, Precipitation, and discoloration, and particularly excellent in water dispersibility, and uses thereof.
  • the physiologically active substance is a trace amount of a substance that greatly affects the function and physiological function of the living body, and includes vitamins, hydroxy acids, unsaturated fatty acids, hormones, enzymes, neurotransmitters and the like.
  • Physiologically active substances such as vitamins, salicylic acid, hydroxy acids, unsaturated fatty acids and glutathione (GLT) have functions such as antioxidation, acne treatment, skin whitening, exfoliation, starch removal, skin moisturizing and wrinkle prevention
  • GLT glutathione
  • vitamins including vitamins A (retinol), vitamin C (ascorbic acid), vitamin E (tocopherol) and derivatives thereof are widely used in the field of cosmetics. They are used for preventing skin whitening and pigmentation, promoting collagen synthesis, Prevention of dryness and keratinization of skin, prevention of wrinkles, skin moisturization and so on. Despite these effects, however, it has many limitations in practical applications due to the instability of vitamin, irritation, toxicity, dispersibility and the disadvantage that it is easily destroyed by heat, light, oxygen.
  • the volcanic soil is a soil formed by the formation of the soil after the high and far ash (ash) is deposited on the ground at the time of the volcanic eruption. It is characterized by porosity and low specific density. Therefore, it shows excellent ability to hold moisture, excellent in pollution treatment and antibacterial action.
  • the weight of the soil per unit volume is 0.54 g / cm 3, which is significantly lower than 1.2 g / cm 3 of the land area general soil and the porosity is 75%, which is much larger than about 50% Is fast.
  • the present invention is applied to maintain good water quality by adsorbing power to pesticides of soil using excellent adsorption characteristics of pollutants. That is, the possibility of the ceramic carrier is suggested by using the permeability and adsorption force due to the pores of the clay soil.
  • the present inventors have made efforts to efficiently carry weakly physiologically active substances against the external environment such as air, light, heat, pH, moisture, and the like.
  • volcanic ash as a porous material is selected as an inorganic carrier material
  • the physiologically active substance is supported on the pores, the micropores are enclosed with the ionic polymer to protect the physiologically active substance from the external environment, and due to van der Waals bonding between the ionic polymer residue exposed on the surface and the nonionic polymer substance, To prevent self-agglomeration.
  • there was no dropout, precipitation, discoloration, and in particular, excellent water dispersibility was confirmed, thereby completing the present invention.
  • An object of the present invention is to provide a composite in which a porous material, which is a porous material, is used as an inorganic carrier and a physiologically active substance is stably supported.
  • Another object of the present invention is to provide a cosmetic, food or pharmaceutical field using the same, which has no dropout, settling, discoloration and excellent water dispersibility after the production of the composite.
  • the present invention provides a method for preparing a porous material, comprising the steps of supporting a physiologically active substance on micropores of a porous material, encapsulating the micropores into an ionic polymer, and exposing the surface to ionic polymer residues and non- To form a network due to van der Waals bonding and to stabilize the water dispersibility.
  • the complex of the present invention contains 10 to 30 parts by weight of the physiologically active substance per 100 parts by weight of the volcanic ash, 1 to 10 parts by weight of the ionic polymer and 1 to 10 parts by weight of the nonionic polymer, .
  • the physiologically active substance may be selected from the group consisting of vitamin A, vitamin C, vitamin E, salicylic acid, kojic acid, alpha-lipoic acid, elacydic acid, resveratrol, docohexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid and glutathione Or a mixed form of them may be applied.
  • the ionic polymer is any one selected from the group consisting of alginic acid, pectin, carrageenan, xanthan gum, hyaluronic acid, gum Arabic, karaya gum and tragacanth gum.
  • nonionic polymer is selected from the group consisting of starch or cyclotin.
  • the present invention provides a functional product in which the complex is applied to any one selected from the group consisting of cosmetics, foods, and medicines, and is embodied by a physiologically active substance.
  • the present invention can provide a physiologically active substance complex using a porous material and a polymer. That is, not only is it possible to effectively support various physiologically active substances in the micropores of the clay soil, but also to increase the stability by enclosing the physiologically active substances carried on micropores of the clayey soil with ionic polymers, It is possible to protect the physiologically active substance enclosed in the micropores from the external environment and prevent coagulation and precipitation between physiologically active substances, thereby maintaining the inherent physiological activity of the substance as it is.
  • the complex of the present invention is not only environmentally friendly but also skin-friendly and has high stability to aqueous solution, so that it can be applied not only to raw materials for functional cosmetics but also to industrial fields such as foods and pharmaceuticals, .
  • Fig. 1 schematically shows a composite structure of the present invention.
  • the present invention provides a composite using a porous material and a polymer.
  • Figure 1 schematically shows the composite structure of the present invention.
  • the composite of the present invention is characterized in that the composite of the present invention is formed by supporting a physiologically active substance in micropores of a porous material, sealing the micropores with an ionic polymer, And forms a network due to Van der Waals bonding between the exposed ionic polymer residue and the nonionic polymer.
  • the porous material to be used can be applied as long as it can be used as a conventional inorganic carrier having a micropore.
  • volcanic soil has been selected and described in the embodiments of the present invention, it will be understood that silica, zeolite and the like can also be applied.
  • a complex using a volcanic ash selected as a porous material will be described in detail.
  • 10 to 50 parts by weight of a physiologically active substance is supported on 100 parts by weight of a volcanic ash, 1 to 10 parts by weight of an ionic polymer 1 to 10 parts by weight of a non-ionic polymer is contained and stabilized.
  • the ionic polymer binds to the entrance of the micropores to protect and stabilize the physiologically active substances from the external environment.
  • the hydrophobic residues of the ionic polymer exposed to the surface of the complex due to not being incorporated into the micropores form a network due to the interaction of non-ionic polymers with Van der Waals, thereby causing self-aggregation between the complexes And to increase the dispersion of the aqueous solution.
  • the volcanic ash used in the present invention is a stabilized colloidal solution by stirring or ultrasonicating 0.01 to 1% by weight in distilled water at room temperature.
  • the physiologically active substance there may be mentioned retinoic acid, ascorbic acid, vitamin E (tocopherol), salicylic acid, kojic acid, alpha-lipoic acid lipoic acid, ellagic acid, resveratrol, docohexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid (LA) , Glutathione, or a mixed form thereof.
  • DHA docohexaenoic acid
  • EPA eicosapentaenoic acid
  • LA linoleic acid
  • Glutathione or a mixed form thereof.
  • the present invention is not limited thereto, and may be changed depending on the application field.
  • the physiologically active substance is supported on 100 parts by weight of the volcanic ash.
  • the ionic polymers used in the present invention may be selected from the group consisting of alginic acid, pectin, carrageenans, xanthan gum, hyaluronic acid, Arabic gum, Karaya gum, and Tragacanth gum.
  • the ionic polymer is used in an amount of 1 to 10 parts by weight, more preferably 2 to 3 parts by weight, based on 100 parts by weight of the volcanic ash. At this time, if the ionic polymer content is less than 1 part by weight, hwasanto to the stabilization after the carry of a biomolecule lack the micro pores and the storage period 4 weeks elapsed time, the precipitation occurs in the third week, or a problem of discoloration Table 2 ]. On the other hand, when the amount is more than 10 parts by weight, precipitation or discoloration is not observed. However, when the excess amount is insufficient, the effect improvement effect is insufficient, and the more the remaining unbonded amount is, the more the nonionic polymer content is increased.
  • starch or cyclodextrin is used as the nonionic polymeric substance.
  • a natural polymer which has little or no bio-toxicity and which can be skin-friendly and environmentally friendly.
  • a physiologically active substance supported on a volcanic soil is stabilized, So as to have a stable dispersion degree.
  • the nonionic polymer is preferably used in an amount of 1 to 10 parts by weight, more preferably 1 to 3 parts by weight, based on 100 parts by weight of the volcanic ash. At this time, or the ionic polymer content is less than 1 part by weight, when the weight exceeds 10 parts, the precipitation or color change occurred in the storage period Week 4 [Table 3].
  • the present invention relates to a method for preparing a stable colloid by stirring or ultrasonically dispersing a volcanic ash, mixing 100 parts by weight of a volcanic ash and 10 to 30 parts by weight of a physiologically active substance to carry a biologically active substance on the micropores of the volcanic ash,
  • the present invention provides a method for producing a composite comprising three steps of inhibiting self-aggregation of a complex through a network of a non-ionic polymer and a residue of an anionic polymer exposed on the surface of the composite.
  • the step 1 is a step of stably supporting a physiologically active substance on the micropores of a porous material, which is a porous material.
  • the physiologically active substance is mixed with 100 parts by weight of the volatile earth by stirring or ultrasonication at 0 to 4 ⁇ , Separate and wash and re-disperse in distilled water.
  • the volcanic ash is mixed with distilled water at a rate of 0.01 to 1 wt% at room temperature or by ultrasonication to produce a stable colloidal solution.
  • stirring is performed for more than 24 hours for 1 hour or more, and the colloid solution is centrifuged to remove the precipitate, thereby finally obtaining a stable volcanic colloid.
  • the physiologically active substance is prepared by dissolving the selected physiologically active substance to 0.1 wt% in distilled water at 4 to 20 ° C.
  • sodium hydroxide is added in an equivalent ratio of 1: Dissolve.
  • step 2 the micropores are sealed with an anionic polymer to protect the supported physiologically active substance from the external environment such as air, light, heat, pH, moisture, and the like, thereby preparing a stabilized complex.
  • step 3 1 to 10 parts by weight of a nonionic polymer is added to the redispersed composite solution in step 2, and the mixture is stirred or ultrasonicated at 4 to 20 ° C, followed by centrifugation and washing with distilled water. .
  • the polymer selected in the second and third steps is used in distilled water in an amount of 0.01 to 1% by weight.
  • the weight ratio of the polymer to water is too high, the viscosity of the solution is excessively increased or difficult to be dissolved by the polymer, so that the preparation of the complex is not easy.
  • the weight ratio of the polymer to the distilled water is too low, Lowering the effect of enclosing the physiologically active substance and the stability of the egg / insoluble complex.
  • the average molecular weight of the polymer is preferably 1,000 to 100,000.
  • the temperature of the polymer solution is preferably 20 to 80 DEG C, and the pH of the solution is preferably 5 to 8.
  • the complex of the present invention is not only environmentally friendly but also skin-friendly and highly stable to an aqueous solution, so that it can be applied to foods and medicines which are required to stabilize a target substance as well as a raw material for functional cosmetics.
  • the present invention provides a functional cosmetic comprising the above-mentioned complex and having a functional property by the supported physiologically active substance.
  • the present invention also provides functional foods or medicines based on physiologically active substances including the complex.
  • a solution of 0.1% vitamin C in 100 g of a 0.1% volcanic acid dispersion was mixed in the amounts shown in Table 1 below. Thereafter, the mixture was stirred at 4 ° C for 24 hours, centrifuged and washed, lyophilized, and the mass of the powder was measured. The amount of physiologically active substance loaded on the volcanic soil was calculated by the following equation.
  • reaction is carried out by stirring the redispersed physiologically active substance / volcanic acid solution and the anionic polymer solution at 4 ° C for 24 hours, centrifuging and washing, and adding the nonionic polymer solution to 100 g of the prepared composite dispersion solution followeded by stirring at 4 ° C for 24 hours for centrifugation and washing.
  • the final product was dispersed in 100 g of distilled water.
  • a complex was prepared as shown in Table 2 below using 0.1% hyaluronic acid as an anionic polymer and 0.1% starch as a nonionic polymer.
  • the composites prepared in each Example were stored at 50 < 0 > C and observed for sedimentation and discoloration.
  • the stabilization of the complex supports that the anionic polymer and the non-ionic polymer form a network to improve the stability of the egg / insoluble substance in the aqueous solution.
  • the anionic polymer shown in the following Table 3 was added to the redispersed solution, stirred at 4 DEG C for 24 hours, centrifuged and washed, and redispersed in 100 g of distilled water.
  • the non-ionic polymer was added to 100 g of the redispersed composite redispersion solution, followed by centrifugation and washing at 4 DEG C for 24 hours with stirring.
  • the final product was dispersed in 100 g of distilled water and stored at 50 ° C to observe sedimentation and discoloration. The results are shown in Table 3 below.
  • the ionic polymer when physiologically active substances are supported by physical interaction with micropores of a porous material, which is a porous material, the ionic polymer is bound to the entrance of micropores to protect and stabilize physiologically active substances from the external environment.
  • the hydrophobic residues of the ionic polymer exposed on the surface of the composite of the present invention form a network by interaction of non-ionic polymers with Van der Waals, thereby suppressing self-agglomeration between the complexes and enhancing water dispersibility, Since it is not only environmentally friendly but also skin-friendly and highly stable to aqueous solution, it can be applied not only to raw materials for functional cosmetics but also to industrial fields such as foods and medicines that require stabilization of the target substance.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a composite using a porous material and a polymer, and a use thereof. The composite of the present invention includes a bioactive substance supported on the micropores of volcanic soil, which is a porous material, the micropores being capped with an ionic polymer so as to protect the bioactive substance from the external environment, and includes a network formed through Van der Waals bonding between ionic polymer moieties, which are exposed to the surface after capping, and a nonionic polymer so as to prevent self-aggregation, thereby preventing separation, precipitation and discoloration after the composite is prepared and, particularly, providing remarkable water dispersibility, and thus is readily applied to the cosmetics, food or medical field using the same and can implement functionality by the supported bioactive substance.

Description

다공성 물질과 고분자를 이용한 복합체 및 그를 이용한 용도Composite using porous material and polymer and use thereof
본 발명은 다공성 물질과 고분자를 이용한 복합체 및 그를 이용한 용도에 관한 것으로서, 더욱 상세하게는 다공성 물질인 화산토(volcanic soil)의 미세공에 생리활성물질을 담지하고, 상기 미세공에 이온성 고분자를 봉입(capping)함으로써 외부 환경으로부터 생리활성물질을 보호하고, 봉입 이후 표면에 노출된 이온성 고분자 잔기와 비이온성 고분자간의 반데르발스 결합으로 인해 네트워크를 형성시켜 자가응집을 방지함으로써, 복합체 제조 이후 탈락, 침전, 변색이 없고 특히, 수분산성이 우수한 복합체 및 그를 이용한 용도에 관한 것이다. The present invention relates to a composite using a porous material and a polymer and a use thereof. More particularly, the present invention relates to a composite material comprising a porous material, a physiologically active substance supported on the micropores of a volcanic soil and an ionic polymer The present invention relates to a method for protecting a biologically active material from external environment by capping and preventing self aggregation by forming a network due to Van der Waals bonding between an ionic polymer residue exposed on a surface and a nonionic polymer after sealing, Precipitation, and discoloration, and particularly excellent in water dispersibility, and uses thereof.
생리활성물질은 미량으로 생체의 기능 및 생리 작용에 큰 영향을 미치는 물질로서 비타민, 하이드록시산, 불포화지방산, 호르몬, 효소, 신경 전달 물질 등을 포함한다. The physiologically active substance is a trace amount of a substance that greatly affects the function and physiological function of the living body, and includes vitamins, hydroxy acids, unsaturated fatty acids, hormones, enzymes, neurotransmitters and the like.
상기 비타민, 살리실산을 비롯한 하이드록시산, 불포화지방산 및 글루타치온 (glutathione, GLT)과 같은 생리활성물질은 항산화, 여드름 치료, 피부 미백, 각질 제거, 기미 제거, 피부 보습, 주름 방지 등의 기능을 가지는 것으로 알려져 있으나, 빛이나 고온에서 산화되어 변색, 변취를 일으킬 수 있어 실제 응용에 많은 제약이 따르고 있다. Physiologically active substances such as vitamins, salicylic acid, hydroxy acids, unsaturated fatty acids and glutathione (GLT) have functions such as antioxidation, acne treatment, skin whitening, exfoliation, starch removal, skin moisturizing and wrinkle prevention However, it is oxidized at light or high temperature and can cause discoloration and irrigation, so that there are many restrictions on practical applications.
특히, 화장품 분야에서 각광받고 있는 원료로서, 비타민 A(retinol), 비타민 C(ascorbic acid), 비타민 E(tocopherol) 및 그 유도체 등을 포함하는 비타민은 피부 미백 및 색소 침착 방지, 콜라겐 합성 촉진, 자외선 차단, 피부의 건조와 각화 방지, 주름 방지, 피부 보습 등 매우 중요한 역할을 한다. 그러나 이러한 효과에도 불구하고, 비타민의 불안정성, 자극, 독성, 분산성 문제와 열, 빛, 산소 등에 의해 쉽게 파괴되는 단점 때문에 실제 응용에 있어서 많은 제약을 가지고 있다. Particularly, vitamins including vitamins A (retinol), vitamin C (ascorbic acid), vitamin E (tocopherol) and derivatives thereof are widely used in the field of cosmetics. They are used for preventing skin whitening and pigmentation, promoting collagen synthesis, Prevention of dryness and keratinization of skin, prevention of wrinkles, skin moisturization and so on. Despite these effects, however, it has many limitations in practical applications due to the instability of vitamin, irritation, toxicity, dispersibility and the disadvantage that it is easily destroyed by heat, light, oxygen.
화산토(volcanic soil)는 화산 폭발 당시 높고 멀리 날아간 재(ash)가 지면에 내려앉아 퇴적층을 이룬 뒤, 다시 토양생성작용을 받아 형성된 토양으로, 다공성 및 낮은 전용적 밀도를 특징으로 한다. 따라서, 수분을 잡아두는 높은 보수력, 오염 처리 및 항균 작용에 탁월한 능력을 보이기도 한다. The volcanic soil is a soil formed by the formation of the soil after the high and far ash (ash) is deposited on the ground at the time of the volcanic eruption. It is characterized by porosity and low specific density. Therefore, it shows excellent ability to hold moisture, excellent in pollution treatment and antibacterial action.
그 일례로, 대한민국특허 제1105343호에는 보헤마이트(Al(OH)3), 규석(quartz)과 석고(calcium sulfate hydrate)의 결정상으로 구성된 화산토의 우수한 내수성을 확인하고, 이를 함유하여 중금속의 흡착성능을 향상시키고 깨끗한 물을 하천이나 지하수로 유입시키기 위한 투수성 식생블럭을 개시하고 있다. For example, in Korean Patent No. 1105343, the excellent water resistance of a volcanic ash composed of a crystal phase of boehmite (Al (OH) 3 ), quartz and gypsum (calcium sulfate hydrate) And introducing clean water into the stream or groundwater.
또한, 제주산 흑색화산회토 등을 이용한 세라믹 여재에 관한 보고[제46회 전국과학전람회 출품부문 환경, 제주관광산업고등학교 김형신, 김추식]에 의하면, 토양의 pH, 유기물함량, 점토함량에 따라 오염물질을 여과하는 양과 에너지에 영향을 미치는데, 토양에서의 투수속도는 공극의 크기와 양에 의하여 결정된다고 기술되어 있다. According to the report on the ceramic filter media using the black volcanic ash soil from Jeju [The 46th National Science Exhibition Entrance Environment, Jeju Tourism Industry High School Kim Hyong Shin, Kim Chu Sik], the pollutants It is described that the rate of permeability in soil is determined by the size and amount of pores.
일례로 흑색 화산회토의 경우, 단위부피당 토양의 무게가 0.54g/㎤으로 육지부 일반 토양의 1.2 g/㎤에 비하여 현저히 낮고, 공극률은 75%로서 육지부 토양의 약 50%에 비하여 매우 커서 투수속도가 빠르다고 기술하고 있다. 이외, 오염물질의 우수한 흡착특성을 이용하여 토양의 농약에 대한 흡착력으로 양질의 수질을 유지하는데 적용한다고 보고하고 있다. 즉, 화산토의 공극으로 인한 투수성과 흡착력을 이용하여 세라믹 담체로서의 가능성을 제시하고 있다.For example, in the case of the black volcanic ash soil, the weight of the soil per unit volume is 0.54 g / cm 3, which is significantly lower than 1.2 g / cm 3 of the land area general soil and the porosity is 75%, which is much larger than about 50% Is fast. In addition, it has been reported that the present invention is applied to maintain good water quality by adsorbing power to pesticides of soil using excellent adsorption characteristics of pollutants. That is, the possibility of the ceramic carrier is suggested by using the permeability and adsorption force due to the pores of the clay soil.
이에, 본 발명자들은 공기, 빛, 열, pH, 수분 등의 외부환경에 대해 취약한 생리활성물질을 효율적으로 담지하기 위하여 꾸준히 노력한 결과, 다공성 물질인 화산토를 무기계 담지체 재료로 선정하고 상기 화산토의 미세공에 생리활성물질을 담지하고, 상기 미세공을 이온성 고분자로 봉입하여 외부 환경으로부터 생리활성물질을 보호하고, 표면에 노출된 이온성 고분자 잔기와 비이온성 고분자 물질간의 반데르발스 결합으로 인해 네트워크를 형성시켜 자가응집을 방지함으로써, 복합체 제조 이후 탈락, 침전, 변색이 없고 특히, 우수한 수분산성을 확인함으로써, 본 발명을 완성하였다. Accordingly, the present inventors have made efforts to efficiently carry weakly physiologically active substances against the external environment such as air, light, heat, pH, moisture, and the like. As a result, they have found that volcanic ash as a porous material is selected as an inorganic carrier material, The physiologically active substance is supported on the pores, the micropores are enclosed with the ionic polymer to protect the physiologically active substance from the external environment, and due to van der Waals bonding between the ionic polymer residue exposed on the surface and the nonionic polymer substance, To prevent self-agglomeration. Thus, after the preparation of the composite, there was no dropout, precipitation, discoloration, and in particular, excellent water dispersibility was confirmed, thereby completing the present invention.
본 발명의 목적은 무기계 담지체로서 다공성 물질인 화산토를 활용하고, 생리활성물질을 안정적으로 담지화한 복합체를 제공하는 것이다. An object of the present invention is to provide a composite in which a porous material, which is a porous material, is used as an inorganic carrier and a physiologically active substance is stably supported.
본 발명의 다른 목적은 상기 복합체 제조 이후 탈락, 침전, 변색이 없고 수분산성이 우수하여 이를 이용한 화장료, 식품 또는 의약품 분야에 적용하는 그 용도를 제공하는 것이다. Another object of the present invention is to provide a cosmetic, food or pharmaceutical field using the same, which has no dropout, settling, discoloration and excellent water dispersibility after the production of the composite.
상기 목적을 달성하기 위하여, 본 발명은 다공성 물질인 화산토의 미세공에 생리활성물질이 담지되고, 상기 미세공이 이온성 고분자로 봉입되고, 봉입 이후 표면에 노출된 이온성 고분자 잔기와 비이온성 고분자가 반데르발스 결합으로 인해 네트워크를 형성되어 수분산성이 안정화된 복합체를 제공한다. In order to accomplish the above object, the present invention provides a method for preparing a porous material, comprising the steps of supporting a physiologically active substance on micropores of a porous material, encapsulating the micropores into an ionic polymer, and exposing the surface to ionic polymer residues and non- To form a network due to van der Waals bonding and to stabilize the water dispersibility.
더욱 구체적으로, 본 발명의 복합체는 상기 화산토 100 중량부에 대하여, 생리활성물질 10 내지 30 중량부가 담지되고, 이온성 고분자 1 내지 10 중량부로 봉입된 후 비이온성 고분자 1 내지 10 중량부가 함유되어 안정화된 것이다.More specifically, the complex of the present invention contains 10 to 30 parts by weight of the physiologically active substance per 100 parts by weight of the volcanic ash, 1 to 10 parts by weight of the ionic polymer and 1 to 10 parts by weight of the nonionic polymer, .
이때, 생리활성물질은 비타민 A, 비타민 C, 비타민 E, 살리실산, 코직산, 알파-리포산, 엘라직산, 레스베라트롤, 도코헥사엔산(DHA), 에이코사펜타엔산(EPA), 리놀레산 및 글루타치온으로 이루어진 군에서 선택되는 단독 또는 그들간의 혼합형태를 적용할 수 있다.The physiologically active substance may be selected from the group consisting of vitamin A, vitamin C, vitamin E, salicylic acid, kojic acid, alpha-lipoic acid, elacydic acid, resveratrol, docohexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid and glutathione Or a mixed form of them may be applied.
상기 이온성 고분자는 알긴산, 펙틴, 카라기난, 잔탄검, 하이알루론산, 아리비아검, 카라야검 및 트라가칸스검으로 이루어진 군에서 선택되는 어느 하나인 것이다.The ionic polymer is any one selected from the group consisting of alginic acid, pectin, carrageenan, xanthan gum, hyaluronic acid, gum Arabic, karaya gum and tragacanth gum.
또한, 비이온성 고분자는 녹말 또는 사이클로텍스트린으로 이루어진 군에서 선택되는 것이다.In addition, the nonionic polymer is selected from the group consisting of starch or cyclotin.
나아가, 본 발명은 상기의 복합체가 화장품, 식품 및 의약품으로 이루어진 군에서 선택되는 어느 하나에 적용되어 생리활성물질에 의한 구현되는 기능성 제품을 제공한다. Further, the present invention provides a functional product in which the complex is applied to any one selected from the group consisting of cosmetics, foods, and medicines, and is embodied by a physiologically active substance.
본 발명은 다공성 물질과 고분자를 이용한 생리활성물질 복합체를 제공할 수 있다. 즉, 다공성 물질로서 화산토를 선정하고, 상기 화산토의 미세공에 다양한 생리활성물질을 효과적으로 담지할 수 있을 뿐만 아니라 화산토의 미세공에 담지된 생리활성물질을 이온성 고분자로 봉입하여 안정도를 높임으로써, 미세공에 봉입된 생리활성물질을 외부 환경으로부터 보호하고 생리활성물질 간의 응집 및 석출이 방지되어 물질 고유의 생리활성을 그대로 유지시킬 수 있다.The present invention can provide a physiologically active substance complex using a porous material and a polymer. That is, not only is it possible to effectively support various physiologically active substances in the micropores of the clay soil, but also to increase the stability by enclosing the physiologically active substances carried on micropores of the clayey soil with ionic polymers, It is possible to protect the physiologically active substance enclosed in the micropores from the external environment and prevent coagulation and precipitation between physiologically active substances, thereby maintaining the inherent physiological activity of the substance as it is.
또한, 상기 복합체의 표면에 노출된 이온성 고분자의 잔기를 비이온성 고분자와 반데르발스 결합으로 인해 네트워크를 형성시켜 자가응집을 방지함으로써, 수용액에 대한 분산 안정성을 높일 수 있다.Also, since the residue of the ionic polymer exposed on the surface of the complex is bound to van der Waals by a non-ionic polymer, a network is formed to prevent self-agglomeration, thereby enhancing the dispersion stability of the aqueous solution.
이에, 본 발명의 복합체는 친환경적일 뿐만 아니라 피부친화적이며 수용액에 대한 안정도가 뛰어나기 때문에 기능성 화장품의 원료로 적용할 수 있을 뿐만 아니라 대상 물질의 안정화가 필요한 식품, 의약품 등의 산업 분야에 확대 적용할 수 있다. Thus, the complex of the present invention is not only environmentally friendly but also skin-friendly and has high stability to aqueous solution, so that it can be applied not only to raw materials for functional cosmetics but also to industrial fields such as foods and pharmaceuticals, .
도 1은 본 발명의 복합체 구성을 모식적으로 도시한 것이다. Fig. 1 schematically shows a composite structure of the present invention.
이하, 본 발명을 상세히 설명하고자 한다. Hereinafter, the present invention will be described in detail.
본 발명은 다공성 물질과 고분자를 이용한 복합체를 제공한다. The present invention provides a composite using a porous material and a polymer.
*도 1은 본 발명의 복합체 구성을 모식적으로 도시한 것으로서, 본 발명의 복합체는 다공성 물질의 미세공에 생리활성물질을 담지하고, 상기 미세공에 이온성 고분자로 봉입하고, 봉입 이후 표면에 노출된 이온성 고분자 잔기와 비이온성 고분자간의 반데르발스 결합으로 인해 네트워크를 형성하는 것이다. Figure 1 schematically shows the composite structure of the present invention. The composite of the present invention is characterized in that the composite of the present invention is formed by supporting a physiologically active substance in micropores of a porous material, sealing the micropores with an ionic polymer, And forms a network due to Van der Waals bonding between the exposed ionic polymer residue and the nonionic polymer.
이때, 사용되는 다공성 물질은 미세공(micropore)을 가지는 통상의 무기 담지체로 사용될 수 있는 것이라면 적용 가능하다. 본 발명의 실시예에서는 화산토(volcanic soil)를 선정하고 설명하고 있으나, 실리카, 제올라이트 등에도 적용 가능함은 당연히 이해될 것이다. At this time, the porous material to be used can be applied as long as it can be used as a conventional inorganic carrier having a micropore. Although volcanic soil has been selected and described in the embodiments of the present invention, it will be understood that silica, zeolite and the like can also be applied.
본 발명에서 다공성 물질로 선정된 화산토를 이용한 복합체를 구체적으로 설명하면, 화산토 100 중량부에 대하여, 생리활성물질 10 내지 50 중량부가 담지되고, 상기 미세공에 이온성 고분자 1 내지 10 중량부로 봉입된 후 비이온성 고분자 1 내지 10 중량부가 함유되어 안정화되는 것이다.In the present invention, a complex using a volcanic ash selected as a porous material will be described in detail. In the present invention, 10 to 50 parts by weight of a physiologically active substance is supported on 100 parts by weight of a volcanic ash, 1 to 10 parts by weight of an ionic polymer 1 to 10 parts by weight of a non-ionic polymer is contained and stabilized.
이에, 본 발명의 복합체는 다공성 물질인 화산토의 미세공에 물리적 상호작용을 통해 생리활성물질들이 담지되면, 이온성 고분자를 미세공의 입구에 결합하여 외부 환경으로부터 생리활성물질을 보호하고 안정화한다. 이때, 미세공으로 혼입되지 못하여 복합체의 표면으로 노출된 이온성 고분자의 소수성 잔기는 비이온성 고분자와 반데르발스(Van der Waals) 상호작용으로 네트워크를 형성하여 복합체들간의 자가 응집(self-aggregation)을 억제하고 수용액에 대한 분산도를 높이는 것이다.Accordingly, when the physiologically active substances are supported on the micropores of the porous material, which is a porous material, by physically interacting with the micropores of the porous material, the ionic polymer binds to the entrance of the micropores to protect and stabilize the physiologically active substances from the external environment. At this time, the hydrophobic residues of the ionic polymer exposed to the surface of the complex due to not being incorporated into the micropores form a network due to the interaction of non-ionic polymers with Van der Waals, thereby causing self-aggregation between the complexes And to increase the dispersion of the aqueous solution.
본 발명에서 사용된 화산토는 증류수에 0.01 내지 1중량%를 상온에서 교반 또는 초음파 처리하여 안정한 콜로이드 용액을 제공한다. The volcanic ash used in the present invention is a stabilized colloidal solution by stirring or ultrasonicating 0.01 to 1% by weight in distilled water at room temperature.
또한, 본 발명에서의 실시예에서는 생리활성물질로서, 비타민 A(retinoic acid), 비타민 C(ascorbic acid), 비타민 E(tocopherol), 살리실산(salicylic acid), 코직산(kojic acid), 알파-리포산(α-lipoic acid), 엘라직산(ellagic acid), 레즈베라트롤(resveratrol), 도코헥사엔산(docohexaenoic acid, DHA), 에이코사펜타엔산(eicosapentaenoic acid, EPA), 리놀레산(linoleic acid, LA), 글루타치온(glutathione)으로 이루어진 군에서 선택되는 단독 또는 그들간의 혼합형태를 적용하여 설명하고 있으나, 이에 한정되지 않고, 적용분야에 따라 변경될 수 있을 것이다.In the examples of the present invention, as the physiologically active substance, there may be mentioned retinoic acid, ascorbic acid, vitamin E (tocopherol), salicylic acid, kojic acid, alpha-lipoic acid lipoic acid, ellagic acid, resveratrol, docohexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid (LA) , Glutathione, or a mixed form thereof. However, the present invention is not limited thereto, and may be changed depending on the application field.
또한, 상기 화산토 100 중량부에 대하여, 생리활성물질은 10 내지 30 중량부가 사용되어 담지되는 것이 바람직하다. 이때, 생리활성물질의 함량이 많이 담지 될수록 그로 인한 기능성 구현이 바람직하나, 상기 30 중량부를 초과하면, 담지 되지 않은 양이 증가하므로, 바람직하지 않다[표 1].Also, it is preferable that 10 to 30 parts by weight of the physiologically active substance is supported on 100 parts by weight of the volcanic ash. At this time, the more a lot of the content of the physiologically active substance is preferably supported from the functional implementation thereof, because if it exceeds the 30 parts by weight, the amount of increase is not supported, it is not preferable Table 1.
본 발명에서 사용되는 이온성 고분자는 알긴산(alginic acid), 펙틴(pectin), 카라기난(carrageenans), 잔탄검(xanthan gum), 하이알루론산(hyaluronic acid), 아리비아검(Arabic gum), 카라야검(Karaya gum) 및 트라가칸스검(Tragacanth gum)으로 이루어진 군에서 선택되는 어느 하나를 사용하는 것이다.The ionic polymers used in the present invention may be selected from the group consisting of alginic acid, pectin, carrageenans, xanthan gum, hyaluronic acid, Arabic gum, Karaya gum, and Tragacanth gum.
또한, 상기 화산토 100 중량부에 대하여, 이온성 고분자는 1 내지 10 중량부가 사용되며 더욱 바람직하게는 2 내지 3 중량부가 사용되는 것이다. 이때, 이온성 고분자 함량이 1 중량부 미만이면, 화산토 미세공에 생리활성물질의 담지 후 안정화가 미흡하여 보관기간 4주 경과 시, 3주차에 침전이 발생하거나 변색의 문제가 발생한다[표 2]. 또한, 10 중량부를 초과하면, 침전발생이나 변색문제는 관찰되지 않으나, 지나친 과량은 효과향상효과는 미흡하고 봉입되지 않은 잔량이 많을수록 비이온성 고분자 함량도 증가하므로 수분산성에 불리하다. The ionic polymer is used in an amount of 1 to 10 parts by weight, more preferably 2 to 3 parts by weight, based on 100 parts by weight of the volcanic ash. At this time, if the ionic polymer content is less than 1 part by weight, hwasanto to the stabilization after the carry of a biomolecule lack the micro pores and the storage period 4 weeks elapsed time, the precipitation occurs in the third week, or a problem of discoloration Table 2 ]. On the other hand, when the amount is more than 10 parts by weight, precipitation or discoloration is not observed. However, when the excess amount is insufficient, the effect improvement effect is insufficient, and the more the remaining unbonded amount is, the more the nonionic polymer content is increased.
본 발명의 복합체에는 비이온성 고분자 물질로서 녹말(starch) 또는 사이클로덱스트린(cyclodextrin)을 사용하는 것이다.In the complex of the present invention, starch or cyclodextrin is used as the nonionic polymeric substance.
이상의 이온성 또는 비이온성 고분자(polymer)는 생체 독성이 거의 없으며 피부친화적이고 환경친화적 개발이 가능한 천연 고분자를 선택하는 것이 바람직하며, 본 발명에서는 화산토에 담지된 생리활성물질을 안정화시키고 형성된 복합체가 수용액에서 안정한 분산도를 가질 수 있도록 하기 위하여 선정된다.It is preferable to select a natural polymer which has little or no bio-toxicity and which can be skin-friendly and environmentally friendly. In the present invention, a physiologically active substance supported on a volcanic soil is stabilized, So as to have a stable dispersion degree.
또한, 상기 화산토 100 중량부에 대하여, 비이온성 고분자는 1 내지 10 중량부, 더욱 바람직하게는 1 내지 3 중량부가 사용되는 것이 바람직하다. 이때, 이온성 고분자 함량이 1 중량부 미만이거나, 10 중량부를 초과하면, 보관기간 4주차에 침전 및 변색이 발생된다[표 3].The nonionic polymer is preferably used in an amount of 1 to 10 parts by weight, more preferably 1 to 3 parts by weight, based on 100 parts by weight of the volcanic ash. At this time, or the ionic polymer content is less than 1 part by weight, when the weight exceeds 10 parts, the precipitation or color change occurred in the storage period Week 4 [Table 3].
이에 본 발명의 복합체 제조 이후 4주 경과 후에도 탈락, 침전, 변색이 관찰되지 않고, 다공성 물질인 화산토를 이용하여 다양한 생리활성물질을 효과적으로 담지하고 고분자로 봉입 및 네트워크 형성하여 생리활성물질이 외부 환경으로부터 보호되고 안정화된 복합체를 제조하고 수용액에 대하여 분산도를 개선할 수 있다.Therefore, it is possible to effectively remove various physiologically active substances from the porous material and to encapsulate them with a polymer and to form a network by using the porous material, which is not observed to be detached, precipitated, or discolored even after 4 weeks from the production of the complex of the present invention. Protected and stabilized complexes can be prepared and the dispersion degree improved over aqueous solutions.
이에, 본 발명은 화산토를 교반 또는 초음파 분산하여 안정한 콜로이드를 준비하고 화산토 100 중량부 및 생리활성물질 10 내지 30 중량부를 혼합하여 상기 화산토의 미세공에 생리활성물질을 담지하는 1단계, Accordingly, the present invention relates to a method for preparing a stable colloid by stirring or ultrasonically dispersing a volcanic ash, mixing 100 parts by weight of a volcanic ash and 10 to 30 parts by weight of a physiologically active substance to carry a biologically active substance on the micropores of the volcanic ash,
상기 미세공을 이온성 고분자로 봉입하여 담지된 생리활성물질이 안정화된 복합체를 형성하는 2단계 및 A second step of enclosing the micropores with an ionic polymer to form a stabilized complex of the supported physiologically active substance, and
상기 복합체 표면으로 노출된 음이온성 고분자의 잔기와 비이온성 고분자의 네트워크 형성을 통해 복합체간의 자가 응집(self-aggregation)을 억제하는 3단계로 이루어진 복합체의 제조방법을 제공한다.The present invention provides a method for producing a composite comprising three steps of inhibiting self-aggregation of a complex through a network of a non-ionic polymer and a residue of an anionic polymer exposed on the surface of the composite.
이하, 본 발명의 복합체의 제조방법을 각 단계별로 상세히 설명한다.Hereinafter, the method for producing the composite of the present invention will be described in detail for each step.
상기 1단계는 다공성 물질인 화산토의 미세공에 생리활성물질을 안정적으로 담지하는 단계로서, 화산토 100 중량부에 대하여, 생리활성물질 10 내지 30 중량부를 0∼4℃에서 교반 또는 초음파 처리한 후 원심분리 및 세척하고 증류수에 재분산한다. The step 1 is a step of stably supporting a physiologically active substance on the micropores of a porous material, which is a porous material. The physiologically active substance is mixed with 100 parts by weight of the volatile earth by stirring or ultrasonication at 0 to 4 캜, Separate and wash and re-disperse in distilled water.
이때, 화산토는 증류수에 0.01 내지 1중량%를 상온에서 교반 또는 초음파 처리하여 안정한 콜로이드 용액을 제조한다. 이때, 교반은 24시간 이상 초음파 처리는 1시간 이상 수행하며, 상기 콜로이드 용액을 원심분리하여 침전 물질을 제거하는 과정을 통해 최종적으로 안정한 화산토 콜로이드를 수득한다. At this time, the volcanic ash is mixed with distilled water at a rate of 0.01 to 1 wt% at room temperature or by ultrasonication to produce a stable colloidal solution. At this time, stirring is performed for more than 24 hours for 1 hour or more, and the colloid solution is centrifuged to remove the precipitate, thereby finally obtaining a stable volcanic colloid.
또한, 상기 선택된 생리활성물질은 4 내지 20℃에서 증류수에 0.1 중량%가 되도록 용해하여 준비하며, 아스코빅산(ascorbic acid)을 제외한 생리활성물질의 경우 수산화나트륨을 1:1 당량비가 되도록 첨가하여 완전히 용해시킨다.In addition, the physiologically active substance is prepared by dissolving the selected physiologically active substance to 0.1 wt% in distilled water at 4 to 20 ° C. In the case of a physiologically active substance other than ascorbic acid, sodium hydroxide is added in an equivalent ratio of 1: Dissolve.
상기 2단계는 미세공을 음이온성 고분자로 봉입하여 담지된 생리활성물질을 공기, 빛, 열, pH, 수분 등의 외부환경으로부터 보호하고, 안정화된 복합체를 제조하는 단계이다. In step 2, the micropores are sealed with an anionic polymer to protect the supported physiologically active substance from the external environment such as air, light, heat, pH, moisture, and the like, thereby preparing a stabilized complex.
구체적으로는, 1단계에서 재분산된 용액에 화산토 100 중량부 대비 이온성 고분자 1 내지 10 중량부를 첨가하여 4 내지 20℃에서 교반 또는 초음파 처리한 후 원심분리 및 증류수에 세척하고 복합체를 재분산한다.Specifically, 1 to 10 parts by weight of an ionic polymer is added to the redispersed solution in 100 parts by weight of the volcanic ash, and the mixture is stirred or sonicated at 4 to 20 DEG C, followed by centrifugation and washing with distilled water. .
이후, 3단계는 상기 2단계에서 재분산된 복합체 용액에 화산토 100 중량부 대비 비이온성 고분자 1 내지 10 중량부를 첨가하여 4 내지 20℃에서 교반 또는 초음파 처리한 후 원심분리 및 증류수에 세척하고 최종 복합체를 분산하는 것으로 이루어진다. Then, in step 3, 1 to 10 parts by weight of a nonionic polymer is added to the redispersed composite solution in step 2, and the mixture is stirred or ultrasonicated at 4 to 20 ° C, followed by centrifugation and washing with distilled water. .
상기 2단계 및 3단계에서 선택된 고분자는 증류수에 0.01 내지 1중량%를 사용한다. 물에 대한 고분자의 중량비가 너무 높을 경우, 고분자들에 의해서 용액의 점도가 지나치게 상승하거나 용해가 어려워 복합체 제조가 용이하지 않고, 반대로 증류수에 대한 고분자의 중량비가 너무 낮을 경우, 복합체 혹은 분자 간 결합력이 낮아져 생리활성물질의 봉입효과 및 난/불용성 복합체의 안정도가 낮아진다. The polymer selected in the second and third steps is used in distilled water in an amount of 0.01 to 1% by weight. When the weight ratio of the polymer to water is too high, the viscosity of the solution is excessively increased or difficult to be dissolved by the polymer, so that the preparation of the complex is not easy. Conversely, when the weight ratio of the polymer to the distilled water is too low, Lowering the effect of enclosing the physiologically active substance and the stability of the egg / insoluble complex.
또한, 고분자 평균 분자량은 1,000∼100,000을 사용하는 것이 바람직하다. 또한, 고분자 용액 제조 시 온도는 20∼80℃에서 수행하며, 용액의 pH는 5∼8로 유지하는 것이 바람직하다. The average molecular weight of the polymer is preferably 1,000 to 100,000. The temperature of the polymer solution is preferably 20 to 80 DEG C, and the pH of the solution is preferably 5 to 8.
이상의 복합체의 제조방법을 통해, 화산토의 미세공에 다양한 생리활성물질을 효과적으로 담지할 수 있을 뿐만 아니라 화산토의 미세공에 담지된 생리활성물질을 이온성 고분자로 봉입하여 안정도를 높임으로써, 미세공에 봉입된 생리활성물질을 외부 환경으로부터 보호하고 생리활성물질 간의 응집 및 석출이 방지되어 물질 고유의 생리활성을 그대로 유지시킬 수 있다.Through the above-described method for producing a complex, not only can various physiologically active substances be effectively supported on the micro pores of the clay soil, but also the physiologically active substance supported on the micro pores of the clay soil is sealed with the ionic polymer to improve the stability, The encapsulated physiologically active substance is protected from the external environment and coagulation and precipitation of the physiologically active substance are prevented so that the inherent physiological activity of the substance can be maintained.
또한, 상기 복합체의 표면에 노출된 이온성 고분자의 잔기를 비이온성 고분자와 반데르발스 결합으로 인해 네트워크를 형성시켜 자가응집을 방지함으로써, 수용액에 대한 분산 안정성을 높일 수 있다.Also, since the residue of the ionic polymer exposed on the surface of the complex is bound to van der Waals by a non-ionic polymer, a network is formed to prevent self-agglomeration, thereby enhancing the dispersion stability of the aqueous solution.
이에, 본 발명의 복합체는 친환경적일 뿐만 아니라 피부친화적이며 수용액에 대한 안정도가 뛰어나기 때문에 기능성 화장품의 원료로 적용할 수 있을 뿐만 아니라 대상 물질의 안정화가 필요한 식품, 의약품에 적용할 수 있다. Thus, the complex of the present invention is not only environmentally friendly but also skin-friendly and highly stable to an aqueous solution, so that it can be applied to foods and medicines which are required to stabilize a target substance as well as a raw material for functional cosmetics.
나아가, 본 발명은 상기의 복합체를 포함하고, 담지된 생리활성물질에 의한 기능성이 구현된 기능성 화장료를 제공한다. Further, the present invention provides a functional cosmetic comprising the above-mentioned complex and having a functional property by the supported physiologically active substance.
또한, 상기의 복합체를 포함한 생리활성물질에 의한 기능성 식품 또는 의약품을 제공한다. The present invention also provides functional foods or medicines based on physiologically active substances including the complex.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. Hereinafter, the present invention will be described in more detail with reference to Examples.
본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. The present invention is intended to more specifically illustrate the present invention, and the scope of the present invention is not limited to these embodiments.
<제조예 1∼5> 화산토에 생리활성물질의 담지량 결정&Lt; Preparation Examples 1 to 5 > Determination of loading amount of physiologically active substance on volcanic soil
0.1% 화산토 분산액 100g에 0.1% 비타민 C 용액을 하기 표 1에 제시된 바와 같은 사용량으로 혼합하였다. 이후 4℃에서 24시간 동안 교반한 후 원심분리 및 세척, 동결 건조한 후 분말의 질량을 측정하였다. 화산토에 대한 생리활성물질의 담지량은 아래 식을 통하여 계산하였다.A solution of 0.1% vitamin C in 100 g of a 0.1% volcanic acid dispersion was mixed in the amounts shown in Table 1 below. Thereafter, the mixture was stirred at 4 ° C for 24 hours, centrifuged and washed, lyophilized, and the mass of the powder was measured. The amount of physiologically active substance loaded on the volcanic soil was calculated by the following equation.
Figure PCTKR2018000113-appb-I000001
Figure PCTKR2018000113-appb-I000001
Figure PCTKR2018000113-appb-I000002
Figure PCTKR2018000113-appb-I000002
상기 표 1의 결과로부터, 화산토에 비타민 C를 24시간 동안 담지한 결과, 화산토 1g당 약 30%의 생리활성물질을 최대로 담지할 수 있음을 확인하였다.From the results shown in Table 1, it was confirmed that about 30% of the physiologically active substance per 1 g of the volcanic soil can be supported at the maximum when the vitamin C was carried on the volcanic soil for 24 hours.
<실시예 1∼6> 고분자에 의한 생리활성물질 안정화 및 분산도 확인<Examples 1 to 6> Confirmation of stabilization and dispersion of physiologically active substance by polymer
상기 제조예를 근거하여 0.1% 화산토 분산액 100g과 0.1% 비타민 C 용액 30g을 4℃에서 24시간 동안 교반한 후 원심분리 및 세척하고 증류수 100g에 재분산하였다. 이때, 비타민 C는 변색 여부로 생리활성물질의 변형을 판단하기 용이하기 위하여 선택되었다.Based on the above preparation example, 100 g of the 0.1% volcanic earth dispersion and 30 g of the 0.1% vitamin C solution were stirred at 4 캜 for 24 hours, centrifuged and washed, and redispersed in 100 g of distilled water. At this time, vitamin C was selected in order to easily determine the deformation of the physiologically active substance due to discoloration.
이후, 반응은 재분산된 생리활성물질/화산토 용액과 음이온성 고분자 용액을 4℃에서 24시간 동안 교반한 후 원심분리 및 세척하는 단계와 제조된 복합체 재분산 용액 100g에 비이온성 고분자 용액을 첨가한 후 4℃에서 24시간 동안 교반하여 원심분리 및 세척하는 단계를 실시하였다. 최종 생성물을 100g의 증류수에 분산하였다.Thereafter, the reaction is carried out by stirring the redispersed physiologically active substance / volcanic acid solution and the anionic polymer solution at 4 ° C for 24 hours, centrifuging and washing, and adding the nonionic polymer solution to 100 g of the prepared composite dispersion solution Followed by stirring at 4 ° C for 24 hours for centrifugation and washing. The final product was dispersed in 100 g of distilled water.
이때, 음이온성 고분자로서 0.1% 히알루론산을 사용하고, 비이온성 고분자로서 0.1% 녹말을 사용하여 하기 표 2에 제시된 바와 같이 복합체를 제조하였다. 각 실시예에서 제조된 복합체는 50℃에서 보관하면서 침전과 변색 여부를 관찰하였다. At this time, a complex was prepared as shown in Table 2 below using 0.1% hyaluronic acid as an anionic polymer and 0.1% starch as a nonionic polymer. The composites prepared in each Example were stored at 50 &lt; 0 &gt; C and observed for sedimentation and discoloration.
Figure PCTKR2018000113-appb-I000003
Figure PCTKR2018000113-appb-I000003
상기 표 2의 결과로부터, 화산토에 비타민 C가 안정적으로 담지된 복합체를 제조할 때, 화산토 100g에 대하여, 음이온성 고분자는 2g 이상, 비이온성 고분자는 1g 이상 사용될 경우, 수용액에서의 분산 안정도가 증가하였다. 또한, 보관기간 4주 경과 후에도 침전이나 비타민 C의 변색이 관찰되지 아니한 최적의 범위를 안출하였다. From the results shown in the above Table 2, it can be seen that when an anionic polymer is used in an amount of 2 g or more and 100 g of a nonionic polymer is used in an amount of 1 g or more, Respectively. In addition, the optimum range in which sedimentation and discoloration of vitamin C were not observed even after 4 weeks of storage were found.
상기 복합체의 안정화는 음이온성 고분자와 비이온성 고분자가 네트워크를 형성하여 수용액 상에서 난/불용성 물질의 안정도를 향상시킬 수 있음을 뒷받침한다. The stabilization of the complex supports that the anionic polymer and the non-ionic polymer form a network to improve the stability of the egg / insoluble substance in the aqueous solution.
<실시예 7∼20> 음이온성 고분자 종류별 복합체 제조 및 물성평가&Lt; Examples 7 to 20 > Preparation of complexes by anionic polymer type and evaluation of physical properties
표 2의 결과를 근거하여, 복합체의 안정화를 확인한 함량비율로서, 화산토 분산액 100g에 비타민 C 30g을 담지 할 때, 음이온 고분자 함량 2g, 비이온성 고분자 함량을 1g으로 고정하고, 음이온 고분자 및 비이온성 고분자의 종류를 변경한 것을 제외하고는, 동일하게 수행하였다. Based on the results shown in Table 2, when 30 g of vitamin C was supported on 100 g of the volcanic earth dispersion, the content of the anionic polymer was fixed to 2 g and the content of the nonionic polymer was fixed to 1 g, and the amount of the anionic polymer and the nonionic polymer Except that the kind of the catalyst was changed.
구체적으로, 0.1% 화산토 분산액 100g과 0.1% 비타민 C 용액 30g을 4℃에서 24시간 동안 교반한 후 원심분리 및 세척하고 증류수 100g에 재분산하였다.Specifically, 100 g of a 0.1% volcanic earth dispersion and 30 g of a 0.1% vitamin C solution were stirred at 4 캜 for 24 hours, centrifuged and washed, and redispersed in 100 g of distilled water.
상기 재분산된 용액에 하기 표 3에 제시된 음이온성 고분자를 첨가하고 4℃에서 24시간 동안 교반한 후 원심분리 및 세척하고 증류수 100g에 재분산하였다. 이후 상기 재분산된 복합체 재분산 용액 100g에, 비이온성 고분자를 첨가한 후 4℃에서 24시간 동안 교반하여 원심분리 및 세척하였다. 최종 생성물은 100g의 증류수에 분산한 후 50℃에서 보관하면서 침전과 변색여부를 관찰하였다. 그 결과를 하기 표 3에 기재하였다.The anionic polymer shown in the following Table 3 was added to the redispersed solution, stirred at 4 DEG C for 24 hours, centrifuged and washed, and redispersed in 100 g of distilled water. The non-ionic polymer was added to 100 g of the redispersed composite redispersion solution, followed by centrifugation and washing at 4 DEG C for 24 hours with stirring. The final product was dispersed in 100 g of distilled water and stored at 50 ° C to observe sedimentation and discoloration. The results are shown in Table 3 below.
Figure PCTKR2018000113-appb-I000004
Figure PCTKR2018000113-appb-I000004
상기 표 3의 결과에서 나타난 바와 같이, 다양한 음이온성 고분자를 사용하고 최적의 함량비로 제조한 화산토에 비타민 C가 안정적으로 담지된 복합체는 사용한 경우, 보관기간 4주 경과 후에도 침전이나 비타민 C의 변색이 관찰되지 않았으므로, 침전 안정도와 변색 안정도를 확인하였다. As shown in the results of Table 3, when a composite in which vitamin C was stably supported on a volcanic soil prepared using various anionic polymers at an optimum content ratio was used, precipitation or discoloration of vitamin C even after 4 weeks of storage No precipitation stability and discoloration stability were observed.
<실시예 21∼30> 생리활성물질 종류별 복합체 제조 및 물성평가&Lt; Examples 21 to 30 > Preparation of composites by physiologically active substance type and evaluation of physical properties
상기 표 2의 최적함량비율 및 표 3의 음이온성 고분자 종류별 실험을 근거하여, 화산토 분산액 100g에 생리활성물질 30g을 담지 할 때, 음이온 고분자로서 히알루론산 2g, 비이온성 고분자로서 녹말 1g 사용을 고정하고, 다양한 생리활성물질의 종류를 변경한 것을 제외하고는, 동일하게 수행하였다. 최종 생성물은 100g의 증류수에 분산한 후 50℃에서 보관하면서 침전과 변색여부를 관찰하였다. 그 결과를 하기 표 4에 기재하였다. Based on the optimum content ratio in Table 2 and the anionic polymer type in Table 3, when 30 g of the physiologically active substance was supported on 100 g of the volcanic ash dispersion, 2 g of hyaluronic acid as an anion polymer and 1 g of starch as a nonionic polymer were fixed , And the kinds of various physiologically active substances were changed. The final product was dispersed in 100 g of distilled water and stored at 50 ° C to observe sedimentation and discoloration. The results are shown in Table 4 below.
Figure PCTKR2018000113-appb-I000005
Figure PCTKR2018000113-appb-I000005
상기 표 4의 결과로부터, 화산토에 다양한 생리활성물질이 음이온성 고분자와 비이온성 고분자와의 최적함량으로 반응함으로써, 보관기간 4주 경과 후에도 침전이나 변색이 관찰되지 않았으므로, 침전 안정도와 변색 안정도를 확인하였다. From the results of Table 4, it can be seen that the sedimentation stability and the discoloration stability were improved because the various physiologically active substances in the volcanic soil reacted with the optimal contents of the anionic polymer and the nonionic polymer, Respectively.
이러한 결과는 본 발명의 방법에 따라 다양한 생리활성물질을 침전안정도 및 변색안정도를 구비한 복합체로 적용될 수 있음을 뒷받침한다. These results support that various physiologically active substances can be applied as complexes having sedimentation stability and discoloration stability according to the method of the present invention.
상기에서 살펴본 바와 같이, 본 발명은 다공성 물질인 화산토의 미세공에 물리적 상호작용을 통해 생리활성물질들이 담지되면, 이온성 고분자를 미세공의 입구에 결합하여 외부 환경으로부터 생리활성물질을 보호하고 안정화한 복합체를 제공하였다. As described above, according to the present invention, when physiologically active substances are supported by physical interaction with micropores of a porous material, which is a porous material, the ionic polymer is bound to the entrance of micropores to protect and stabilize physiologically active substances from the external environment. Lt; / RTI &gt;
또한, 본 발명의 복합체 표면에 노출된 이온성 고분자의 소수성 잔기는 비이온성 고분자와 반데르발스(Van der Waals) 상호작용으로 네트워크를 형성하여 복합체들간의 자가 응집을 억제하고 수분산성을 높임으로써, 친환경적일 뿐만 아니라 피부친화적이며 수용액에 대한 안정도가 뛰어나기 때문에 기능성 화장품의 원료로 적용할 수 있을 뿐만 아니라 대상 물질의 안정화가 필요한 식품, 의약품 등의 산업 분야에 확대 적용할 수 있다.In addition, the hydrophobic residues of the ionic polymer exposed on the surface of the composite of the present invention form a network by interaction of non-ionic polymers with Van der Waals, thereby suppressing self-agglomeration between the complexes and enhancing water dispersibility, Since it is not only environmentally friendly but also skin-friendly and highly stable to aqueous solution, it can be applied not only to raw materials for functional cosmetics but also to industrial fields such as foods and medicines that require stabilization of the target substance.
이상에서 본 발명은 기재된 구체예에 대해서만 상세히 설명되었지만 본 발명의 기술사상 범위 내에서 다양한 변형 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속함은 당연한 것이다.While the invention has been shown and described with reference to certain exemplary embodiments thereof, it will be understood by those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (6)

  1. 다공성 물질인 화산토의 미세공에 생리활성물질이 담지되고, 상기 미세공이 이온성 고분자로 봉입되고, 봉입 이후 표면에 노출된 이온성 고분자 잔기와 비이온성 고분자간의 반데르발스 결합에 의해 수분산성이 안정화된 복합체.The physiologically active substance is supported on the micropores of the porous material which is the porous material, the micropores are encapsulated by the ionic polymer, and the water dispersibility is stabilized by van der Waals bonding between the ionic polymer residue exposed on the surface after the sealing and the nonionic polymer Complex.
  2. 제1항에 있어서, 상기 화산토 100 중량부에 대하여, 생리활성물질 10 내지 30 중량부가 담지되고, 이온성 고분자 1 내지 10 중량부로 봉입된 후 비이온성 고분자 1 내지 10 중량부가 함유되어 안정화된 것을 특징으로 하는 복합체.The method of claim 1, wherein 10 to 30 parts by weight of the physiologically active substance is supported on 100 parts by weight of the volcanic ash, 1 to 10 parts by weight of the ionic polymer is contained, and 1 to 10 parts by weight of the nonionic polymer is stabilized &Lt; / RTI &gt;
  3. 제1항에 있어서, 상기 생리활성물질이 비타민 A, 비타민 C, 비타민 E, 살리실산, 코직산, 알파-리포산, 엘라직산, 레스베라트롤, 도코헥사엔산(DHA), 에이코사펜타엔산(EPA), 리놀레산 및 글루타치온으로 이루어진 군에서 선택되는 단독 또는 그들간의 혼합형태인 것을 특징으로 하는 복합체.The method of claim 1, wherein the physiologically active substance is selected from the group consisting of vitamin A, vitamin C, vitamin E, salicylic acid, kojic acid, alpha-lipoic acid, elastic acid, resveratrol, docohexaenoic acid (DHA), eicosapentaenoic acid (EPA) Linoleic acid, and glutathione, or a mixed form thereof.
  4. 제1항에 있어서, 상기 이온성 고분자가 알긴산, 펙틴, 카라기난, 잔탄검, 하이알루론산, 아리비아검, 카라야검 및 트라가칸스검으로 이루어진 군에서 선택되는 어느 하나인 것을 특징으로 하는 복합체.The complex according to claim 1, wherein the ionic polymer is any one selected from the group consisting of alginic acid, pectin, carrageenan, xanthan gum, hyaluronic acid, gum Arabic, karaya gum and tragacanth gum.
  5. 제1항에 있어서, 상기 비이온성 고분자가 녹말 또는 사이클로텍스트린에서 선택되는 것을 특징으로 하는 복합체.The complex according to claim 1, wherein the nonionic polymer is selected from starch or cyclotin.
  6. 제1항 내지 제5항 중 어느 한 항의 복합체가 화장품, 식품 및 의약품으로 이루어진 군에서 선택되는 어느 하나에 적용되어 생리활성물질에 의한 구현되는 기능성 제품.The functional product according to any one of claims 1 to 5, which is applied to any one selected from the group consisting of cosmetics, foods and medicines, and is embodied by a physiologically active substance.
PCT/KR2018/000113 2018-01-03 2018-01-03 Composite using porous material and polymer, and use thereof WO2019135420A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/KR2018/000113 WO2019135420A1 (en) 2018-01-03 2018-01-03 Composite using porous material and polymer, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2018/000113 WO2019135420A1 (en) 2018-01-03 2018-01-03 Composite using porous material and polymer, and use thereof

Publications (1)

Publication Number Publication Date
WO2019135420A1 true WO2019135420A1 (en) 2019-07-11

Family

ID=67143755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/000113 WO2019135420A1 (en) 2018-01-03 2018-01-03 Composite using porous material and polymer, and use thereof

Country Status (1)

Country Link
WO (1) WO2019135420A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
WO2009113522A1 (en) * 2008-03-11 2009-09-17 あすか製薬株式会社 Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
KR20100120244A (en) * 2004-10-25 2010-11-12 니뽄 다바코 산교 가부시키가이샤 Solid medicinal preparation improved in solubility and stability and process for producing the same
KR20170038679A (en) * 2015-09-30 2017-04-07 (주)아모레퍼시픽 Complex Powder of Porous Polymer Containing Scoria Powder Particle, Cosmetic Composition Comprising Thereof and the Manufacturing Method Thereof
US20170246111A1 (en) * 2014-09-15 2017-08-31 Pharmasol Gmbh Active-loaded particulate materials for topical administration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
KR20100120244A (en) * 2004-10-25 2010-11-12 니뽄 다바코 산교 가부시키가이샤 Solid medicinal preparation improved in solubility and stability and process for producing the same
WO2009113522A1 (en) * 2008-03-11 2009-09-17 あすか製薬株式会社 Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
US20170246111A1 (en) * 2014-09-15 2017-08-31 Pharmasol Gmbh Active-loaded particulate materials for topical administration
KR20170038679A (en) * 2015-09-30 2017-04-07 (주)아모레퍼시픽 Complex Powder of Porous Polymer Containing Scoria Powder Particle, Cosmetic Composition Comprising Thereof and the Manufacturing Method Thereof

Similar Documents

Publication Publication Date Title
Wang et al. Characterization, release, and antioxidant activity of curcumin-loaded sodium alginate/ZnO hydrogel beads
Lvov et al. Clay nanotube encapsulation for functional biocomposites
Wang et al. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery
Kevadiya et al. Layered bionanocomposites as carrier for procainamide
EP0099109B1 (en) Process for preparing free-flowing ethylcellulose microcapsules
GB2030161A (en) Process for stabilizing dyestuffs sensitive to light and/or oxidation
KR870700209A (en) Method for preparing instant homogeneous micro wexel suspension
CN101703480B (en) Gelatin-chitosan/montmorillonite drug carried microspheres and preparation method thereof
WO2011071239A2 (en) Solubilization method for partially soluble / insoluble active substances through formation of oligomer composite
CN102199312A (en) Mesoporous silica particle compound carrier with controlled-release function as well as preparation method and application thereof
KR20140033122A (en) Process for producing inorganic particulate material
Wang et al. Preparation of cellulose based microspheres by combining spray coagulating with spray drying
Hassanpouraghdam et al. In-vitro evaluation of the 5-fluorouracil loaded GQDs@ Bio-MOF capped with starch biopolymer for improved colon-specific delivery
AU2014356854B2 (en) Process for producing inorganic particulate material
WO2019135420A1 (en) Composite using porous material and polymer, and use thereof
ES2728252T3 (en) Use of silicon oxide based material for the modified release of biologically active agents
CA1317547C (en) Anhydrous application form of low molecular alkali huminates
CN103497344B (en) For nanogel and preparation method thereof and the application of carried noble metal particle
WO2018044035A1 (en) Oil-in-water type cosmetic composition
CN108653239B (en) Epigallocatechin gallate nano sustained-release preparation and preparation method thereof
CN113730374B (en) Sugar beet pectin-based oral sustained-release gel beads and preparation method thereof
KR20180006779A (en) Composite containing porous material and polymer and its use using the same
CN109453139A (en) A kind of LBL self-assembly nano-carrier and preparation method comprising 5 FU 5 fluorouracil
KR20090088614A (en) Drug delivery system of inorganic plate powders-mesoporous silica composite and a method for preparing the same
WO2016098961A1 (en) Cosmetic iron capsule and production method for same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18898048

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18898048

Country of ref document: EP

Kind code of ref document: A1